Vicarious Surgical Inc (NYSE:RBOT) Sees Significant Increase in Short Interest

Vicarious Surgical Inc (NYSE:RBOT) saw a significant growth in short interest in February. As of February 28th, there was short interest totalling 110,800 shares, a growth of 30.4% from the February 13th total of 85,000 shares. Based on an average trading volume of 48,500 shares, the short-interest ratio is presently 2.3 days. Approximately 2.1% of the shares of the stock are short sold.

Hedge Funds Weigh In On Vicarious Surgical

A number of large investors have recently bought and sold shares of the stock. Renaissance Technologies LLC boosted its stake in shares of Vicarious Surgical by 11.6% during the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock valued at $152,000 after purchasing an additional 1,200 shares during the period. DnB Asset Management AS raised its holdings in Vicarious Surgical by 21.1% during the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock valued at $279,000 after buying an additional 3,692 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in Vicarious Surgical by 8.2% during the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock valued at $405,000 after buying an additional 2,336 shares during the period. 47.27% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Piper Sandler lowered their price target on Vicarious Surgical from $10.50 to $8.50 and set a “neutral” rating on the stock in a research report on Tuesday.

Vicarious Surgical Stock Performance

RBOT traded down $1.44 during midday trading on Tuesday, hitting $8.20. The stock had a trading volume of 26,531 shares, compared to its average volume of 33,008. Vicarious Surgical has a 1 year low of $4.27 and a 1 year high of $19.00. The business has a fifty day moving average of $12.70 and a 200 day moving average of $10.59. The company has a market cap of $48.42 million, a P/E ratio of -0.80 and a beta of 1.35.

Vicarious Surgical (NYSE:RBOT) last released its quarterly earnings data on Monday, March 17th. The company reported ($2.43) EPS for the quarter, topping the consensus estimate of ($2.69) by $0.26. The company had revenue of $2.09 million during the quarter. During the same quarter in the prior year, the company posted ($2.25) EPS. On average, equities research analysts anticipate that Vicarious Surgical will post -10.89 earnings per share for the current year.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.